Cytokinetics Debt-to-Assets Ratio Growth & History (CYTK)

Cytokinetics's debt-to-assets ratio was 0.29 for fiscal 2025.

View full Cytokinetics company overview

Cytokinetics annual debt-to-assets ratio history

Cytokinetics annual debt-to-assets ratio

Fiscal yearPeriod endedDebt-to-assets ratioChangeGrowth
20252025-12-310.290.12+72.50%
20242024-12-310.17−0.08−33.11%
20232023-12-310.250.05+23.96%
20222022-12-310.20−0.01−2.60%
20212021-12-310.210.12+125.59%
20202020-12-310.09−0.09−48.25%
20192019-12-310.18−0.02−10.90%
20182018-12-310.200.09+86.33%
20172017-12-310.11−0.07−38.63%
20162016-12-310.180.05+38.25%
20152015-12-310.130.13
20142014-12-310.00

Cytokinetics debt-to-assets ratio trends

Over the last five fiscal years, Cytokinetics's debt-to-assets ratio increased from 0.09 to 0.29, a change of 0.20. The latest reported quarter, Q2 2026, shows 0.21.

About the metric

What the debt-to-assets ratio means

The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.

Calculation and source

How debt-to-assets is calculated

TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Cytokinetics source filings ↗

Community posts

It’s quiet here.

No posts about CYTK yet. Start the conversation.

Write the first post